{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:22:12Z","timestamp":1790220132160,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T00:00:00Z","timestamp":1580083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["neuromodulationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromodulation: Technology at the Neural Interface"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1111\/ner.13097","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T21:59:29Z","timestamp":1580162369000},"page":"996-1002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Intrathecal Baclofen for Severe Spasticity: Longitudinal Data From the Product Surveillance Registry"],"prefix":"10.1016","volume":"23","author":[{"given":"Mya Caryn","family":"Schiess","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9250-1886","authenticated-orcid":false,"given":"Sam","family":"Eldabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Konrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Molus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Stromberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Plunkett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/ner.13097_bib1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4103\/1658-354X.121087","article-title":"Spasticity \u2013 pathogenesis, prevention and treatment strategies","volume":"7","author":"Ghai","year":"2013","journal-title":"Saudi J Anaesth"},{"key":"10.1111\/ner.13097_bib2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2340\/16501977-2211","article-title":"Efficacy and safety of oral baclofen in the management of spasticity: a rationale for intrathecal baclofen","volume":"49","author":"Ertzgaard","year":"2017","journal-title":"J Rehabil Med"},{"key":"10.1111\/ner.13097_bib3","series-title":"Clinical Commissioning Policy: Intrathecal Baclofen (ITB)","year":"2013"},{"key":"10.1111\/ner.13097_bib4","doi-asserted-by":"crossref","first-page":"e007517","DOI":"10.1136\/bmjopen-2014-007517","article-title":"The need for and provision of intrathecal baclofen therapy for the management of spasticity in England: an assessment of the Hospital Episode Statistic database","volume":"5","author":"Narendran","year":"2015","journal-title":"BMJ Open"},{"key":"10.1111\/ner.13097_bib5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/ner.12220","article-title":"Medical cost impact of intrathecal baclofen therapy for severe spasticity","volume":"18","author":"Saulino","year":"2015","journal-title":"Neuromodulation"},{"key":"10.1111\/ner.13097_bib6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/14737167.2016.1180247","article-title":"Cost-effectiveness of intrathecal baclofen therapy in severe refractory non-focal disabling spasticity: a Spanish hospital perspective","volume":"17","author":"Vidal","year":"2017","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1111\/ner.13097_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0883073807299976","article-title":"Cost-effectiveness of intrathecal baclofen therapy for the treatment of severe spasticity associated with cerebral palsy","volume":"22","author":"Lissovoy","year":"2007","journal-title":"J Child Neurol"},{"key":"10.1111\/ner.13097_bib8","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/ner.12524","article-title":"Intrathecal drug delivery systems (IDDS): The Implantable Systems Performance Registry (ISPR)","volume":"19","author":"Konrad","year":"2016","journal-title":"Neuromodulation"},{"key":"10.1111\/ner.13097_bib9","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3171\/jns.1993.78.2.0226","article-title":"Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study","volume":"78","author":"Coffey","year":"1993","journal-title":"J Neurosurg"},{"key":"10.1111\/ner.13097_bib10","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3171\/jns.1996.85.3.0452","article-title":"Chronic intrathecal delivery of baclofen by a programmable pump for the treatment of severe spasticity","volume":"85","author":"Ordia","year":"1996","journal-title":"J Neurosurg"},{"key":"10.1111\/ner.13097_bib11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3171\/jns.2003.98.2.0291","article-title":"Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin","volume":"98","author":"Albright","year":"2003","journal-title":"J Neurosurg"},{"key":"10.1111\/ner.13097_bib12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3171\/jns.1997.87.3.0415","article-title":"Prospective assessment of continuous intrathecal infusion of baclofen for spasticity caused by acquired brain injury: a preliminary report","volume":"87","author":"Meythaler","year":"1997","journal-title":"J Neurosurg"},{"key":"10.1111\/ner.13097_bib13","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.apmr.2006.08.323","article-title":"Intrathecal baclofen management of poststroke spastic hypertonia: implications for function and quality of life","volume":"87","author":"Ivanhoe","year":"2006","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1111\/ner.13097_bib14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1525-1403.2010.00308.x","article-title":"Prospective 12-month study of intrathecal baclofen therapy for poststroke spastic upper and lower extremity motor control and functional improvement","volume":"14","author":"Schiess","year":"2011","journal-title":"Neuromodulation"},{"key":"10.1111\/ner.13097_bib15","first-page":"1","article-title":"Intrathecal baclofen therapy versus conventional medical management for severe poststroke spasticity: results from a multicenter, randomized, controlled, open-label trial (SISTERS)","volume":"0","author":"Creamer","year":"2018","journal-title":"J Neuro Neurosurg Psychiatr"},{"key":"10.1111\/ner.13097_bib16","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1525-1403.2012.00476.x","article-title":"Polyanalgesic Consensus Conference 2012: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel","volume":"15","author":"Deer","year":"2012","journal-title":"Neuromodulation"},{"key":"10.1111\/ner.13097_bib17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(85)90228-4","article-title":"Continuous intrathecal baclofen for severe spasticity","volume":"2","author":"Penn","year":"1985","journal-title":"Lancet"},{"key":"10.1111\/ner.13097_bib18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1525-1403.2008.00170.x","article-title":"Long-term outcomes of continuous intrathecal baclofen infusion for treatment of spasticity: a prospective multicenter follow-up study","volume":"11","author":"Delhaas","year":"2008","journal-title":"Neuromodulation"},{"key":"10.1111\/ner.13097_bib19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF02766064","article-title":"Intrathecal baclofen for severe spasticity: a meta-analysis","volume":"3","author":"Creedon","year":"1997","journal-title":"Int J Rehabil Health"},{"key":"10.1111\/ner.13097_bib20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/ner.12258","article-title":"Intrathecal pump: an abrupt intermittent pump failure","volume":"18","author":"Riordan","year":"2015","journal-title":"Neuromodulation."},{"key":"10.1111\/ner.13097_bib21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/AAP.0000000000000368","article-title":"Sudden intrathecal drug delivery device motor stalls: a case series","volume":"42","author":"Galica","year":"2016","journal-title":"Reg Anesth Pain Med"},{"key":"10.1111\/ner.13097_bib22","doi-asserted-by":"crossref","first-page":"575168","DOI":"10.5402\/2012\/575168","article-title":"Complications of intrathecal baclofen pump: prevention and cure","volume":"2012","author":"Awaad","year":"2012","journal-title":"ISRN Neurol"},{"key":"10.1111\/ner.13097_bib23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/1744-1633.12308","article-title":"Blessing or burden? Long-term maintenance, complications and clinical outcome of intrathecal baclofen pumps","volume":"22","author":"Chan","year":"2018","journal-title":"Surg Pract"},{"key":"10.1111\/ner.13097_bib24","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1469-8749.2009.03473.x","article-title":"Survival of individuals with cerebral palsy receiving continuous intrathecal baclofen treatment: a matched-cohort study","volume":"52","author":"Krach","year":"2010","journal-title":"Dev Med Child Neurol"},{"key":"10.1111\/ner.13097_bib25","first-page":"14","article-title":"Mortality in children with cerebral palsy treated with intrathecal baclofen pump [abstr]","volume":"85","author":"Vedanarayanan","year":"2015","journal-title":"Neurology"},{"key":"10.1111\/ner.13097_bib26","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3171\/2009.6.PEDS0921","article-title":"Infections related to intrathecal baclofen therapy in children and adults: frequency and risk factors","volume":"4","author":"Fjelstad","year":"2009","journal-title":"J Neurosurg Pediatr"}],"container-title":["Neuromodulation: Technology at the Neural Interface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fner.13097","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ner.13097","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ner.13097","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094715921002051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094715921002051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ner.13097","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:57:17Z","timestamp":1761083837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094715921002051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1094715921002051"],"URL":"https:\/\/doi.org\/10.1111\/ner.13097","relation":{},"ISSN":["1094-7159"],"issn-type":[{"value":"1094-7159","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intrathecal Baclofen for Severe Spasticity: Longitudinal Data From the Product Surveillance Registry","name":"articletitle","label":"Article Title"},{"value":"Neuromodulation: Technology at the Neural Interface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ner.13097","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 International Neuromodulation Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}